This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2023
Title: Innovations by Nicholas Jendzjowsky in Cardiorespiratory Measurement
Introduction
Nicholas Jendzjowsky is an innovative inventor based in Calgary, Canada. He has made significant contributions to the field of medical technology, particularly in the measurement of cardiorespiratory responses. His work focuses on understanding the sympathetic nervous system and its impact on vascular health.
Latest Patents
Jendzjowsky holds a patent for a "System and method for measuring cardiorespiratory response." This invention encompasses systems and methods designed to measure sympathetic nervous system activity or blood vessel autoregulation, corrected for sympathetic activity. The patent details a process where the choroid in the human eye is imaged, allowing for the measurement of vascular perfusion density (VPD). This measurement is directly related to sympathetic nervous system activity. By comparing pre-stimuli VPD measurements with post-stimuli measurements, the effects of various stimuli on sympathetic nervous system activity can be quantified. Additionally, altered sympathetic nervous system activity can be detected by comparing a subject's VPD measurements to baseline measurements from healthy individuals.
Career Highlights
Throughout his career, Jendzjowsky has focused on advancing medical technologies that enhance our understanding of human physiology. His innovative approach to measuring VPD has the potential to improve diagnostic methods for various cardiovascular conditions.
Collaborations
Jendzjowsky has collaborated with notable colleagues, including Richard A Wilson and Robert Herman. These partnerships have contributed to the development and refinement of his patented technologies.
Conclusion
Nicholas Jendzjowsky's work in measuring cardiorespiratory responses represents a significant advancement in medical technology. His innovative patent has the potential to enhance our understanding of sympathetic nervous system activity and improve patient diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile